We are live on ! Find out more
ACM

Anfield Capital Management Portfolio holdings

AUM $363M
1-Year Est. Return 24.08%
This Fund
S&P 500
This Quarter Est. Return
-1.78%
1 Year Est. Return
+24.08%
3 Year Est. Return
+65.24%
5 Year Est. Return
+71.54%
10 Year Est. Return
AUM
$273M
AUM Growth
-$16.5M
Cap. Flow
-$5.82M
Cap. Flow %
-2.13%
Top 10 Hldgs %
59.72%
Holding
140
New
40
Increased
34
Reduced
18
Closed
45
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDVY icon
76
First Trust Rising Dividend Achievers ETF
RDVY
$25.6B
$245K 0.09%
5,000
AIG icon
77
American International
AIG
$41.3B
$203K 0.07%
+3,241
New +$195K
LH icon
78
Labcorp
LH
$25.9B
$172K 0.06%
760
+561
+282% +$132K
HZNP
79
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$152K 0.06%
+1,442
New +$141K
INCY icon
80
Incyte
INCY
$24.4B
$114K 0.04%
+1,438
New +$105K
BKT icon
81
BlackRock Income Trust
BKT
$341M
$59K 0.02%
3,818
-803
-17% -$12.6K
CHE icon
82
Chemed
CHE
$7.22B
$54K 0.02%
+106
New +$50.8K
EXEL icon
83
Exelixis
EXEL
$13.4B
$50K 0.02%
+2,219
New +$43.3K
HALO icon
84
Halozyme
HALO
$12.2B
$37K 0.01%
937
+670
+251% +$23.9K
CPRX
85
DELISTED
Catalyst Pharmaceutical
CPRX
$30K 0.01%
3,603
+2,010
+126% +$14.2K
QDEL icon
86
QuidelOrtho
QDEL
$838M
$28K 0.01%
248
+178
+254% +$19K
INVA icon
87
Innoviva
INVA
$1.48B
$23K 0.01%
1,206
+660
+121% +$11.8K
SDIV icon
88
Global X SuperDividend ETF
SDIV
$1.22B
$21K 0.01%
+607
New +$21.5K
CRSP icon
89
CRISPR Therapeutics
CRSP
$5.17B
$19K 0.01%
301
+165
+121% +$10.4K
IRWD icon
90
Ironwood Pharmaceuticals
IRWD
$714M
$19K 0.01%
1,509
+825
+121% +$9.46K
TVTY
91
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$19K 0.01%
+598
New +$16.2K
AMPH icon
92
Amphastar Pharmaceuticals
AMPH
$916M
$18K 0.01%
+509
New +$14.4K
EBS icon
93
Emergent Biosolutions
EBS
$248M
$17K 0.01%
+418
New +$18.4K
VIR icon
94
Vir Biotechnology
VIR
$1.49B
$17K 0.01%
+650
New +$19.3K
QURE icon
95
uniQure
QURE
$3.22B
$10K ﹤0.01%
546
+285
+109% +$4.98K
A icon
96
Agilent Technologies
A
$41.2B
-507
Closed -$81K
AGG icon
97
iShares Core US Aggregate Bond ETF
AGG
$138B
-5,570
Closed -$635K
AMZN icon
98
Amazon
AMZN
$2.96T
-2,560
Closed -$427K
ARKG icon
99
ARK Genomic Revolution ETF
ARKG
$1.73B
-12,535
Closed -$768K
ARKQ icon
100
ARK Autonomous Technology & Robotics ETF
ARKQ
$2.06B
-15,975
Closed -$1.23M

Similar funds

Anfield Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, Anfield Capital Management held 140 positions worth $273M, down 5.7% from $290M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Anfield Capital Management's Q1 2022 filing shows 40 new, 34 increased, 18 reduced and 45 closed positions. Its largest new stake was State Street Energy Select Sector SPDR ETF: 207,116 shares worth $7.92M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $9.33M.

By sector, the portfolio is most concentrated in Financials at 2.6% of assets, down from 2.8% a quarter earlier, followed by Real Estate and Healthcare.

  • Anfield Capital Management's largest Q1 2022 buy was State Street Energy Select Sector SPDR ETF: 207,116 shares worth $7.92M.
  • Anfield Capital Management added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2022, an estimated $8.74M increase.
  • Anfield Capital Management's biggest Q1 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $9.33M.
  • Anfield Capital Management fully exited State Street Communication Services Select Sector SPDR ETF in Q1 2022, selling an estimated $9.24M.
  • Anfield Capital Management's ten largest holdings make up 60% of its $273M portfolio in Q1 2022.
  • Anfield Capital Management opened 40 new positions and closed 45 in Q1 2022.
  • Anfield Capital Management's portfolio value fell 5.7% quarter-over-quarter to $273M.

Based on Anfield Capital Management's 13F filing for Q1 2022, filed 10 May 2022.